High disease activity persists in adults with childhood-onset lupus
Rachel Koelmeyer, Kate Gregory, Rangi Kandane‐Rathnayake, Fiona Goldblatt et autres
0 citationsLupus Science & Medicine
Eric F. Morand
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
606Publications signalées
22774Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesMacrophage Migration Inhibitory FactorMonoclonal and Polyclonal Antibodies ResearchCytokine Signaling Pathways and Interactions
Publications récentes
PROducing More Evidence to Reduce Glucocorticoids in Systemic Lupus Erythematosus: Putting Patient-Reported Outcomes in the Picture
Eric F. Morand, Sarah A. Jones
0 citationsThe Journal of Rheumatology
Systemic lupus erythematosus: Phase 2 trials to watch in 2026
Eric F. Morand, Sarah A. Jones
0 citationsMed
Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study
Zahi Touma, Ian N. Bruce, Richard Furie, Eric F. Morand et autres
0 citationsACR Open Rheumatology
Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study
Luigi Zolio, Yanjie Hao, Rangi Kandane Rathnayake, Worawit Louthrenoo et autres
0 citationsLara D. Veeken
Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network
F. Zazzetti, Ashley Orillion, U. Sbarigia, Anna Sheahan et autres
0 citationsLupus Science & Medicine
PO:07:177 Predictors of the physician’s global assessment (PGA) score among SLE patients in low disease activity
Luigi Zolio, Dylan Hansen, Rangi Kandane-Rathnayake, Worawit Louthrenoo et autres
0 citations
PT7:08 Longitudinal association between LLDAS and remission attainment and improvement in health-related quality of life in patients with systemic lupus erythematosus:a multinational prospective cohort study
Shiori Nakagawa, Worawit Louthrenoo, Alberta Hoi, Vera Golder et autres
0 citations
Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials
Andrea Doria, Ronald van Vollenhoven, Eric F. Morand, Marta Mosca et autres
0 citationsLupus Science & Medicine
Evaluation of Candidate Definitions of Severe Refractory Systemic Lupus Erythematosus Using Clinical Outcomes: Real-World Data Exploration Study
Rangi Kandane‐Rathnayake, Vera Golder, Worawit Louthrenoo, Yi‐Hsing Chen et autres
0 citationsSSRN Electronic Journal
Résultats jusqu’à 12 mois d’une étude phase 1/2 évaluant la tolérance, la cinétique cellulaire et l’efficacité du rapcabtagene autoleucel (YTB323) un CAR-T ciblant le CD19 de fabrication rapide chez des patients avec un lupus érythémateux systémique sévère
Zahir Amoura, Eric F. Morand, Rangi Kandane‐Rathnayake, Josefina Cortés-Hernández et autres
0 citationsLa Revue de Médecine Interne
Predictors of damage accrual by organ domain in systemic lupus erythematosus
Rangi Kandane‐Rathnayake, Luigi Zolio, Jiyoon Choi, Vera Golder et autres
2 citationsLara D. Veeken
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.